Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Can J Cardiol ; 31(1): 3-16, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25532421

RESUMO

The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Update provides discussion on the management recommendations on 3 focused areas: (1) anemia; (2) biomarkers, especially natriuretic peptides; and (3) clinical trials that might change practice in the management of patients with heart failure. First, all patients with heart failure and anemia should be investigated for reversible causes of anemia. Second, patients with chronic stable heart failure should undergo natriuretic peptide testing. Third, considerations should be given to treat selected patients with heart failure and preserved systolic function with a mineralocorticoid receptor antagonist and to treat patients with heart failure and reduced ejection fraction with an angiotensin receptor/neprilysin inhibitor, when the drug is approved. As with updates in previous years, the topics were chosen in response to stakeholder feedback. The 2014 Update includes recommendations, values and preferences, and practical tips to assist the clinicians and health care workers to best manage patients with heart failure.


Assuntos
Anemia/prevenção & controle , Biomarcadores/sangue , Cardiologia/organização & administração , Insuficiência Cardíaca/diagnóstico , Sociedades Médicas/organização & administração , Anemia/sangue , Antagonistas de Receptores de Angiotensina/uso terapêutico , Pressão Sanguínea , Canadá , Ensaios Clínicos como Assunto , Insuficiência Cardíaca/sangue , Insuficiência Cardíaca/tratamento farmacológico , Humanos , Antagonistas de Receptores de Mineralocorticoides/uso terapêutico , Neprilisina/antagonistas & inibidores
2.
Can J Cardiol ; 30(3): 249-63, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24480445

RESUMO

The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update provides focused discussions on the management recommendations on 2 topics: (1) exercise and rehabilitation; and (2) surgical coronary revascularization in patients with heart failure. First, all patients with stable New York Heart Association class I-III symptoms should be considered for enrollment in a tailored exercise training program, to improve exercise tolerance and quality of life. Second, selected patients with suitable coronary anatomy should be considered for bypass graft surgery. As in previous updates, the topics were chosen in response to stakeholder feedback. The 2013 Update also includes recommendations, values and preferences, and practical tips to assist the clinicians and health care workers manage their patients with heart failure.


Assuntos
Cardiologia , Terapia por Exercício/estatística & dados numéricos , Insuficiência Cardíaca/terapia , Revascularização Miocárdica/normas , Guias de Prática Clínica como Assunto , Sociedades Médicas , Canadá , Gerenciamento Clínico , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA